HomeACRV • NASDAQ
Acrivon Therapeutics Inc
add
$1.15
4.55%
After Hours:(0.87%)+0.0100
$1.16
Closed: May 16, 7:15:54 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 21.66M | 22.61% |
Net income | -19.68M | -19.37% |
Net profit margin | — | — |
Earnings per share | -0.51 | 30.14% |
EBITDA | -21.35M | -22.40% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 149.64M | 36.06% |
Total assets | 176.35M | 46.32% |
Total liabilities | 15.96M | 27.24% |
Total equity | 160.39M | — |
Shares outstanding | 31.36M | — |
Price to book | 0.21 | — |
Return on assets | -29.04% | — |
Return on capital | -31.45% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -19.68M | -19.37% |
Cash from operations | -19.54M | -14.35% |
Cash from investing | 19.21M | 228.44% |
Cash from financing | -343.00K | -99.42% |
Net change in cash | -664.00K | 94.18% |
Free cash flow | -16.54M | -31.77% |
Previous close
$1.10
Day range
$1.12 - $1.29
Year range
$1.09 - $10.16
Market cap
36.06M USD
Avg Volume
1.03M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2018
Headquarters
Website
Employees
77
